Combination Intelligence Workbench
Cadenome Technologies Inc.

Combination Intelligent Workspace

From a research question to an evidence-linked scientific dossier.

The Combination Intelligence Workbench—CIW—is being developed as a governed research environment for investigating combinations of compounds within a defined scientific program.

Its intended workflow connects a disease, target, compound or formulation question to an evidence-linked shortlist, an experiment plan and a scientific dossier prepared for qualified review.

Researcher examining a sample under a microscope
A research workspaceNot a treatment recommendation engine

A research workspace, not a treatment recommendation engine

A research workspace, not a treatment recommendation engine

CIW is designed to help teams examine why a combination may warrant further investigation, what evidence challenges it, which uncertainties remain and what would need to be tested.

Its proposed analyses include mechanisms, potential complementarity or antagonism, exposure and pharmacokinetics, interactions, toxicology, formulation considerations and translational limitations.

Research scores are not probabilities of clinical efficacy or safety, and a ranking cannot override a blocking safety finding.

Organize the program, not just the output

Five principal areas

This gives scientific teams a structure for defining the work, examining its evidence, assigning review, preparing its deliverables and understanding its history. CIW is conceived as a separate research application connected to the NPM Integrator environment.

01

Programs

Define the work

02

Evidence

Examine what supports it

03

Reviews

Assign and record review

04

Dossiers

Prepare the deliverables

05

Audit

Understand its history

PDF

Example output

Cadenome Work Space Paper

PDF · 10 pages · example paper for the Combination Intelligence Workspace

Download the example ↓

How CIW differs from the Pharma ↔ Botanical Wizard

How CIW differs from the Pharma ↔ Botanical Wizard

The wizard

Focuses on a guided, bounded pharmaceutical–botanical investigation.

CIW

Addresses the broader research program: candidate comparison, evidence management, scientific review, controlled exploration, experiment planning and dossier preparation.

The planned integration allows relevant claims, evidence gaps, reviews and dossiers to move between the environments while preserving identifiers and versions.

Connect computational work to scientific validation

Connect computational work to scientific validation

An evidence-linked hypothesis is a starting point for investigation, not an experimental result.

CIW’s proposed workflow includes controlled exploration and experiment planning, with quantitative parameters supplied or approved by qualified scientific owners. Laboratory results can inform subsequent evidence review, but the workbench does not autonomously operate a laboratory or replace its approved procedures.

01 Research question Disease, target, compound or formulation
02 Evidence-linked shortlist Candidates with their support and gaps
03 Experiment plan Parameters approved by qualified owners
04 Scientific dossier Prepared for qualified review

Collaborate on a life-sciences project

Bring a defined research challenge. Build the evidence pathway together.

We welcome inquiries from biotechnology and pharmaceutical companies, natural-products developers, universities and research organizations.

A collaboration can begin with a focused question, a defined candidate set, an agreed source plan and a clear review process. Discussions may address a research pilot, a specialized workflow, application integration or an IP licensing arrangement, subject to the relevant rights and agreed scope.

For research and educational use only. Not a clinical recommendation, diagnosis, prescription, or substitute for review by qualified healthcare and scientific professionals.